CS
HLVX

Credit Suisse’s HilleVax HLVX Stock Holding History

Credit Suisse’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$261K Buy
15,688
+3,826
+32% +$61.2K ﹤0.01% 2858
2023
Q4 		$190K Buy
11,862
+1,207
+11% +$16K ﹤0.01% 2994
2023
Q3 		$143K Sell
10,655
-518
-5% -$7.29K ﹤0.01% 3069
2023
Q2 		$192K Buy
+11,173
New +$173K ﹤0.01% 3097
2023
Q1 		– Sell
-9,187
Closed -$154K – 3472
2022
Q4 		$154K Buy
9,187
+9,116
+12,839% +$165K ﹤0.01% 3246
2022
Q3 		$1K Buy
71
+61
+610% +$887 ﹤0.01% 3858
2022
Q2 		$0 Buy
+10
New +$119 ﹤0.01% 4090

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse's HLVX Position: Q1 2024 in Review

Credit Suisse increased its HilleVax (HLVX) stake by 32% in Q1 2024, buying an estimated $61.2K and bringing the position to 15,688 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

Credit Suisse first reported a position in HLVX in Q2 2022 and has held it in 7 quarters since. 81 funds tracked by Wall St. Rank hold HLVX as of Q1 2024.

  • Credit Suisse held 15,688 shares of HilleVax worth $261K as of Q1 2024.
  • Credit Suisse bought 3,826 HilleVax shares in Q1 2024, an estimated $61.2K.
  • HilleVax made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2858 holding.
  • Credit Suisse first reported a position in HilleVax in Q2 2022 and has held it in 7 quarters since.
  • 81 funds tracked by Wall St. Rank held HilleVax as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.